Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial
Activation of GLP-1 receptors has been associated in published research with: glucose-dependent insulin secretion suppression of glucagon release delayed gastric emptying reduced food intake altered central appetite signalling improvements in several metabolic markers Unlike Tirzepatide, Semaglutide does not activate GIP receptors
Vitamin B-12 is essential for energy production and cognitive function
3 This trend mirrors consumer demand for GLP-1s for weight loss, which is higher in the U.S
If you experience unexpected changes in appetite suppression, energy, or side effect severity, report these to your prescriber immediately
This rhythm can be disrupted by factors such as poor sleep, irregular light exposure, high-fat diets, obesity and imbalances in the gut microbiome